KARYDAS DAPHNE sold 32.6% of their position (3K shares) of MINERALYS THERAPEUTICS, INC. on the open market
Open‑market sale worth $75.0K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/18/2026ACC: 0001933414-26-000093
Director
Since Feb 2026
-3K
Net shares
Net seller
$75.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3K acquired · 6K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3K
Price / share
$12.02
Trade value
$36.06K
% of position
48.4%
6/17/2026
6.20K→9.20K
Common Stock
Direct
Shares
−3K
Price / share
$25.00
Trade value
$75K
% of position
32.6%
6/17/2026
9.20K→6.20K
Total
Net shares
+0.00
Net value
-$38.94K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/17/2026 | M · Option Exercise | +3K | $12.02 | $36.06K | 48.4% | 6.20K | 9.20K |
| Common Stock Direct | 6/17/2026 | S · Sale | −3K | $25.00 | $75K | 32.6% | 9.20K | 6.20K |
| Total | +0.00 | -$38.94K | ||||||
Derivative Transactions1
Stock Option
Direct
Converts to
Common Stock
3K shares
Shares
−3K
Strike price
12.02
Held after
38K
Exercisable
—
6/17/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option Direct | Common Stock3K shares | 6/17/2026 | M · Option Exercise | −3K | 12.02 | — | 38K |